Sweden - April 29, 2026
Stockholm Science City’s Ylva Williams sees a more integrated life science region emerging
Once a fragmented landscape of strong research but limited cohesion, Stockholm’s life science ecosystem is now accelerating toward a more integrated future – a shift that Stockholm Science City’s CEO Ylva Williams has helped drive over nearly two decades.
Biotech article - April 20, 2026
In focus: Nasal drug delivery for quicker uptake
Nasal drug delivery is a dynamic area in pharmaceutical innovation. What was once a route for decongestants and allergy sprays is now being explored for everything from emergency treatments to vaccines – and even shows potential for future central nervous system therapies.
Global report - April 6, 2026
Flanders punches above its weight in European biotech
The Belgian region of Flanders has long been one of Europe’s most industrially dynamic regions. Its economy is anchored by advanced manufacturing, logistics, and a life science sector that consistently performs far above the region’s size.
Careers article - March 31, 2026
From curiosity to competence: Rebuilding Nordic youths’ passion for STEM studies
As Sweden crowns its national champions in youth research, the country is grappling with a deeper challenge: how to inspire more young people to pursue science, technology, and maths at a time when PISA results reveal a steady decline in STEM competence across the Nordics.
Profiles in Science - March 23, 2026
Pioneering mitochondrial research earns Dr. Joanna Rorbach the Göran Gustafsson Prize
Dr. Joanna Rorbach, principal researcher at the Department of Medical Biochemistry and Biophysics at Karolinska Institutet, has been awarded the prestigious Göran Gustafsson Prize by the Royal Swedish Academy of Sciences (Kungliga Vetenskapsakademien).
Business article - March 7, 2026
The power loop: How female leadership and women’s health reinforce each other
In a region celebrated for gender equality, the life science sector tells a different story: women dominate the workforce in many jobs yet remain sidelined in leadership, funding, and research – with consequences that ripple across public health and economic performance.